Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study of Thymus Transplantation in Complete DiGeorge Syndrome #668

NCT00576407 is registered in ClinicalTrials.gov with Sumitomo Pharma Switzerland GmbH as lead sponsor.

NCT NCT00576407
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00576407 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study of Thymus Transplantation in Complete DiGeorge Syndrome #668
Lead sponsor
Sumitomo Pharma Switzerland GmbH
Phase
Phase 2
Overall status
Completed
Start date
October 31, 1991
Completion date
December 31, 2017
Enrollment
26 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

complete typical digeorge anomaly, digeorge syndrome